Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 5/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL254939 | 0.90 | SHBG (0.31) | — | |
| SCHEMBL26251806 | 0.86 | CCNT1 (0.30) | — | |
| SCHEMBL11991405 | 0.86 | HCRTR2 (0.38) | HCRTR2 | |
| SCHEMBL4762344 | 0.86 | HCRTR2 (0.38) | HCRTR2 | |
| SCHEMBL17471230 | 0.83 | HCRTR2 (0.32) | HCRTR2 | |
| SCHEMBL25136202 | 0.79 | HCRTR2 (0.32) | HCRTR2 | |
| SCHEMBL10052295 | 0.79 | HCRTR2 (0.33) | HCRTR2 | |
| SCHEMBL19879603 | 0.77 | — | — | |
| SCHEMBL23425967 | 0.76 | DPP4 (0.35) | — | |
| SCHEMBL21466463 | 0.76 | FFAR4 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11420934-B2 | PPAR agonists | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2022-08-23 | — | — | US | disclosed |
| US-20200190019-A1 | PPAR AGONISTS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11420934-B2 | PPAR agonists | PPARG, PPARD, PPARA | HCRTR2 2813/4885 |
| US-20200190019-A1 | PPAR AGONISTS | PPARG, PPARD, PPARA | HCRTR2 2813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.